Cargando…

Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”

Detalles Bibliográficos
Autores principales: Hosmann, Arthur, Millesi, Matthias, Wadiura, Lisa I., Kiesel, Barbara, Mercea, Petra A., Mischkulnig, Mario, Borkovec, Martin, Furtner, Julia, Roetzer, Thomas, Wolfsberger, Stefan, Phillips, Joanna J., Berghoff, Anna S., Hervey-Jumper, Shawn, Berger, Mitchel S., Widhalm, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616458/
https://www.ncbi.nlm.nih.gov/pubmed/34830859
http://dx.doi.org/10.3390/cancers13225705
_version_ 1784604353459388416
author Hosmann, Arthur
Millesi, Matthias
Wadiura, Lisa I.
Kiesel, Barbara
Mercea, Petra A.
Mischkulnig, Mario
Borkovec, Martin
Furtner, Julia
Roetzer, Thomas
Wolfsberger, Stefan
Phillips, Joanna J.
Berghoff, Anna S.
Hervey-Jumper, Shawn
Berger, Mitchel S.
Widhalm, Georg
author_facet Hosmann, Arthur
Millesi, Matthias
Wadiura, Lisa I.
Kiesel, Barbara
Mercea, Petra A.
Mischkulnig, Mario
Borkovec, Martin
Furtner, Julia
Roetzer, Thomas
Wolfsberger, Stefan
Phillips, Joanna J.
Berghoff, Anna S.
Hervey-Jumper, Shawn
Berger, Mitchel S.
Widhalm, Georg
author_sort Hosmann, Arthur
collection PubMed
description
format Online
Article
Text
id pubmed-8616458
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86164582021-11-26 Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” Hosmann, Arthur Millesi, Matthias Wadiura, Lisa I. Kiesel, Barbara Mercea, Petra A. Mischkulnig, Mario Borkovec, Martin Furtner, Julia Roetzer, Thomas Wolfsberger, Stefan Phillips, Joanna J. Berghoff, Anna S. Hervey-Jumper, Shawn Berger, Mitchel S. Widhalm, Georg Cancers (Basel) Reply MDPI 2021-11-15 /pmc/articles/PMC8616458/ /pubmed/34830859 http://dx.doi.org/10.3390/cancers13225705 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Reply
Hosmann, Arthur
Millesi, Matthias
Wadiura, Lisa I.
Kiesel, Barbara
Mercea, Petra A.
Mischkulnig, Mario
Borkovec, Martin
Furtner, Julia
Roetzer, Thomas
Wolfsberger, Stefan
Phillips, Joanna J.
Berghoff, Anna S.
Hervey-Jumper, Shawn
Berger, Mitchel S.
Widhalm, Georg
Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
title Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
title_full Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
title_fullStr Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
title_full_unstemmed Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
title_short Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
title_sort reply to stummer, w.; thomas, c. comment on “hosmann et al. 5-ala fluorescence is a powerful prognostic marker during surgery of low-grade gliomas (who grade ii)—experience at two specialized centers. cancers 2021, 13, 2540”
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616458/
https://www.ncbi.nlm.nih.gov/pubmed/34830859
http://dx.doi.org/10.3390/cancers13225705
work_keys_str_mv AT hosmannarthur replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT millesimatthias replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT wadiuralisai replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT kieselbarbara replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT merceapetraa replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT mischkulnigmario replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT borkovecmartin replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT furtnerjulia replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT roetzerthomas replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT wolfsbergerstefan replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT phillipsjoannaj replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT berghoffannas replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT herveyjumpershawn replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT bergermitchels replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540
AT widhalmgeorg replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540